HI
SLS icon

Harbour Investments’s SELLAS Life Sciences SLS Stock Holding History

Harbour Investments’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$2K – 3535
2021
Q3 		$2K Hold
200
– – ﹤0.01% 3363
2021
Q2 		$2K Hold
200
– – ﹤0.01% 3424
2021
Q1 		$2K Buy
+200
New +$1.64K ﹤0.01% 3266

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbour Investments's SLS Position: Q4 2021 in Review

Harbour Investments sold out of SELLAS Life Sciences (SLS) in Q4 2021, closing a stake of 200 shares — an estimated $2K sold.

Harbour Investments first reported a position in SLS in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 27 funds tracked by Wall St. Rank hold SLS as of Q4 2021.

  • Harbour Investments reported no remaining SELLAS Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 200 SELLAS Life Sciences shares in Q4 2021, an estimated $2K.
  • Harbour Investments first reported a position in SELLAS Life Sciences in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's SELLAS Life Sciences position peaked at $2K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.